According to HCC mouse models, activation of β-catenin pathway was determined to inhibit dendritic cell recruitment in the tumor microenvironment, resulting in inhibition of T cell activation and reduction in CD8-positive T cell infiltration. Here, CD8A is linked to hepatocellular carcinoma.